Drugs That Bind to Purine Receptors and Block Their Activation, Thereby Inhibiting Platelets, Are Mostly Used to Reduce the Risk of Heart Disease and Stroke in High-risk Groups.
This report contains market size and forecasts of Purinergic Receptor Antagonists in Global, including the following market information:
Global Purinergic Receptor Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Purinergic Receptor Antagonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
P2Y Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Purinergic Receptor Antagonists include Sanofi, Bristol Myers Squibb, Apotex, Mylan, AstraZeneca, Chiesi Farmaceutici, Bayer, Zydus Cadila Healthcare and Sun Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Purinergic Receptor Antagonists companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Purinergic Receptor Antagonists Market, by Receptor Type, 2017-2022, 2023-2028 ($ millions)
Global Purinergic Receptor Antagonists Market Segment Percentages, by Receptor Type, 2021 (%)
Global Purinergic Receptor Antagonists Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Purinergic Receptor Antagonists Market Segment Percentages, by Application, 2021 (%)
Global Purinergic Receptor Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Purinergic Receptor Antagonists Market Segment Percentages, By Region and Country, 2021 (%)
Rest of Europe
Rest of Asia
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Purinergic Receptor Antagonists revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Purinergic Receptor Antagonists revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
Zydus Cadila Healthcare